The board of directors of U.S. Bioscience Inc. on Mondaydeclared a 2-for-1 split of the company's common stock in theform of a 100 percent stock dividend.
The dividend will be payable on Jan. 16 to shareholders ofrecord as of Dec. 26. U.S. Bioscience will have 39.2 millionshares outstanding after the split. Shares of the WestConshohocken, Pa., company's stock (AMEX:UBS) rose $2.25 to$78.63 on Monday.
The stock was trading at $39.63 when the company announcedNov. 19 that its Ethyol product to protect normal tissue fromchemotherapy would be reviewed by a Food and DrugAdministration panel.
(c) 1997 American Health Consultants. All rights reserved.